We are live on ! Find out more
CPH

C Partners Holding Portfolio holdings

AUM $317M
1-Year Est. Return 4.76%
This Fund
S&P 500
This Quarter Est. Return
+8%
1 Year Est. Return
-4.76%
3 Year Est. Return
+31.57%
5 Year Est. Return
+26.92%
10 Year Est. Return
+222.73%
AUM
$213M
AUM Growth
-$99.6M
Cap. Flow
-$110M
Cap. Flow %
-51.61%
Top 10 Hldgs %
68.26%
Holding
53
New
7
Increased
12
Reduced
4
Closed
10

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$4.63M
2
BKNG icon
Booking.com
BKNG
+$4.44M
3
VTRS icon
Viatris
VTRS
+$2.7M
4
MDT icon
Medtronic
MDT
+$2.6M
5
MSM icon
MSC Industrial Direct
MSM
+$1.19M

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$77.9M
2
RGLD icon
Royal Gold
RGLD
+$12.5M
3
CBRL icon
Cracker Barrel
CBRL
+$6.04M
4
WAT icon
Waters Corp
WAT
+$5.14M
5
BRCM
BROADCOM CORP CL-A
BRCM
+$4.53M

Sector Composition

Rank Sector Weight
1 Healthcare 20.3%
2 Materials 7.2%
3 Consumer Discretionary 6.55%
4 Consumer Staples 4.39%
5 Technology 4.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAH icon
26
Cardinal Health
CAH
$53.9B
$1.76M 0.82%
21,000
RVTY icon
27
Revvity
RVTY
$12.6B
$1.74M 0.81%
33,000
PRGO icon
28
Perrigo
PRGO
$1.4B
$1.71M 0.8%
9,262
PFE icon
29
Pfizer
PFE
$143B
$1.68M 0.79%
52,700
TEVA icon
30
Teva Pharmaceuticals
TEVA
$40.8B
$1.54M 0.72%
26,000
BIIB icon
31
Biogen
BIIB
$30B
$1.45M 0.68%
3,600
BDSI
32
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.27M 0.6%
160,000
+40,000
+33% +$344K
CERS icon
33
Cerus
CERS
$433M
$1.22M 0.57%
235,000
SYNH
34
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$1.2M 0.56%
30,000
+9,400
+46% +$324K
ALXN
35
DELISTED
Alexion Pharmaceuticals
ALXN
$949K 0.44%
+5,250
New +$906K
PTX
36
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$858K 0.4%
+14,500
New +$1.02M
TMO icon
37
Thermo Fisher Scientific
TMO
$213B
$817K 0.38%
6,300
SYK icon
38
Stryker
SYK
$125B
$765K 0.36%
8,000
RDUS
39
DELISTED
Radius Health, Inc.
RDUS
$548K 0.26%
8,100
-1,500
-16% -$69.9K
AIRM
40
DELISTED
Air Methods Corp
AIRM
$537K 0.25%
+13,000
New +$569K
DVAX
41
DELISTED
Dynavax Technologies
DVAX
$485K 0.23%
20,697
ALPN
42
DELISTED
Alpine Immune Sciences Inc
ALPN
$394K 0.18%
+6,500
New +$387K
SCPX
43
DELISTED
Scorpius Holdings, Inc.
SCPX
0
CBRL icon
44
Cracker Barrel
CBRL
$1.26B
-39,709
Closed -$6.04M
GILD icon
45
Gilead Sciences
GILD
$162B
-37,600
Closed -$3.69M
GOOG icon
46
Alphabet (Google) Class C
GOOG
$4.36T
-142,169
Closed -$3.91M
ISRG icon
47
Intuitive Surgical
ISRG
$127B
-75,294
Closed -$4.22M
RGLD icon
48
Royal Gold
RGLD
$16.8B
-198,254
Closed -$12.5M
WAT icon
49
Waters Corp
WAT
$37B
-41,373
Closed -$5.14M
IPHS
50
DELISTED
Innophos Holdings, Inc.
IPHS
-74,987
Closed -$4.23M

Similar funds

C Partners Holding's Q2 2015 Portfolio in Review

As of Q2 2015, C Partners Holding held 53 positions worth $213M, down 32% from $313M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

C Partners Holding withdrew a net $110M in Q2 2015, closing 10 positions and reducing 4 holdings. Its most notable exit was Royal Gold, an estimated $12.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 15% a quarter earlier, followed by Materials and Consumer Discretionary.

Against the trend, C Partners Holding opened a new position in ExxonMobil worth $4.48M.

  • C Partners Holding's largest Q2 2015 buy was ExxonMobil: 53,900 shares worth $4.48M.
  • C Partners Holding added most to Booking.com in Q2 2015, an estimated $4.44M increase.
  • C Partners Holding's biggest Q2 2015 reduction was SPDR Gold Trust, cutting an estimated $77.9M.
  • C Partners Holding fully exited Royal Gold in Q2 2015, selling an estimated $12.5M.
  • C Partners Holding's ten largest holdings make up 68% of its $213M portfolio in Q2 2015.
  • C Partners Holding opened 7 new positions and closed 10 in Q2 2015.
  • C Partners Holding's portfolio value fell 32% quarter-over-quarter to $213M.

Based on C Partners Holding's 13F filing for Q2 2015, filed 3 Aug 2015.